organophosphonates has been researched along with naphthoquinones in 2 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (naphthoquinones) | Trials (naphthoquinones) | Recent Studies (post-2010) (naphthoquinones) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 7,110 | 149 | 2,923 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, RY; Miao, ZW; Wang, B; Wang, J; Zhang, XD | 1 |
| Li, ZM; Ma, Y; Wang, B; Wang, JG | 1 |
2 other study(ies) available for organophosphonates and naphthoquinones
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel naphthoquinone fused cyclic aminoalkylphosphonates and aminoalkylphosphonic monoester.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; DNA Topoisomerases, Type II; Drug Screening Assays, Antitumor; Esters; HeLa Cells; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Naphthoquinones; Organophosphonates; Stereoisomerism | 2008 |
Integrating molecular docking, DFT and CoMFA/CoMSIA approaches for a series of naphthoquinone fused cyclic α-aminophosphonates that act as novel topoisomerase II inhibitors.
Topics: Binding Sites; Cell Line, Tumor; DNA Topoisomerases, Type II; HeLa Cells; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Conformation; Molecular Dynamics Simulation; Naphthoquinones; Organophosphonates; Protein Binding; Quantitative Structure-Activity Relationship; Topoisomerase II Inhibitors | 2011 |